CXCL10 induces chemotaxis, apoptosis, cell growth inhibition and angiostasis, and CXCL10 concentrations are significantly up-regulated in patients with asthma, COPD, pulmonary tuberculosis, and other airway inflammatory diseases. This evidence concerns the gene CXCL10 and chronic obstructive pulmonary disease.